Organigram Relaunches one of Canada’s First Cannabis Brands, Trailblazer
21 Agosto 2023 - 7:00AM
Business Wire
Trailblazer returns to the Canadian
marketplace with a new range of products
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the
“Company” or “Organigram”), a leading licensed producer of
cannabis, is pleased to announce the relaunch of one of Canada’s
best known cannabis brands, Trailblazer, exemplifying the Company’s
commitment to keeping consumer insights at the heart of its brand
and product development strategy. More than a year in the making,
Trailblazer’s modernized brand identity and revitalized product
lineup represent a significant opportunity to connect with a large
and important consumer segment whose needs were previously unmet by
the Organigram brand portfolio. Featuring THCV gummies, CBG infused
pre-rolls and a high-potency 1x0.5g pre-roll, Trailblazer will
re-enter the market with a range of differentiated offerings.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20230821929092/en/
(Photo: Business Wire)
According to the Company’s segmentation research, the target
audience for the new Trailblazer brand identity represents
approximately $1.2B in total cannabis retail sales.1 One key
differentiating factor for this segment is the prioritization of
whole-plant wellness and the self-administered benefits of the
cannabis plant for restorative needs such as relaxation as opposed
to pure recreational product enjoyment. They also prefer high THC
products and the presence of minor cannabinoids.
The new Trailblazer portfolio consists of three new products,
with additional products expected to be launched in Organigram’s
upcoming fiscal year:
- Cherry Comfort: Diamonds + Distillate Infused THC+CBG
Pre-rolls
- 3 x 0.5g pre-rolls
- +30% THC; +5% CBG with a total cannabinoid potency of +35%
- Each half-gram cone is infused with THC + CBG distillate and
THCA diamonds
- Zen Garden Grapefruit 2:1 THCV: THC Sugar-free Gummies
- 4 sugar-free gummies
- 5 mg of THCV and 2.5 mg THC per gummy
- THCV derived from whole flower grown in Moncton
- Made with natural flavours, THCV and THC distillate
- Dank Dreams: A Potent and Convenient Single Pre-roll
- 0.5g pre-roll
- Curated Indica flower
- High potency with 22-26% THC
“By understanding the unique preferences and aspirations of our
Trailblazer target audience, we strived to create a deeply
rewarding brand experience that fosters a sense of understanding,
positivity, and empowerment. The brand positioning reflects the
emotional aspirations of this consumer segment, reflecting a brand
that is designed for a modern legal cannabis consumer. Trailblazer
aims to create a positive and uplifting experience for its
consumers, supporting them in their cannabis journey”, says Megan
McCrae, Senior Vice President, Marketing and Communications at
Organigram.
About Organigram Holdings Inc. Organigram Holdings Inc.
is a NASDAQ Global Select Market and TSX listed company whose
wholly owned subsidiaries include: Organigram Inc. and Laurentian
Organic Inc., licensed producers of cannabis and cannabis-derived
products in Canada, and The Edibles and Infusions Corporation, a
licensed manufacturer of cannabis-infused edibles in Canada.
Organigram is focused on producing high-quality, cannabis for
patients and adult recreational consumers, as well as developing
international business partnerships to extend the Company’s global
footprint. Organigram has also developed and acquired a portfolio
of legal adult-use recreational cannabis brands, including Edison,
Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour,
Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates
facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec,
with a dedicated edibles manufacturing facility in Winnipeg,
Manitoba. The Company is regulated by the Cannabis Act and the
Cannabis Regulations (Canada).
Forward-Looking Information This news release contains
forward-looking information. Often, but not always, forward-looking
information can be identified by the use of words such as “plans”,
“expects”, “estimates”, “intends”, “anticipates”, “believes” or
variations of such words and phrases or state that certain actions,
events, or results “may”, “could”, “would”, “might” or “will” be
taken, occur or be achieved. Forward-looking information involves
known and unknown risks, uncertainties and other factors that may
cause actual results, events, performance or achievements of
Organigram to differ materially from current expectations or future
results, performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
changes to market conditions, consumer preferences, regulatory
changes and constraints, and factors and risks as disclosed in the
Company’s most recent annual information form, management’s
discussion and analysis and other Company documents filed from time
to time on SEDAR (see www.sedar.com) and filed or furnished to the
Securities and Exchange Commission on EDGAR (see www.sec.gov).
Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date of this
press release. Although the Company believes that the assumptions
and factors used in preparing the forward-looking information in
this news release are reasonable, undue reliance should not be
placed on such information and no assurance can be given that such
events will occur in the disclosed time frames or at all. The
forward-looking information included in this news release are made
as of the date of this news release and the Company disclaims any
intention or obligation, except to the extent required by law, to
update or revise any forward-looking information, whether as a
result of new information, future events or otherwise.
_____________ 1 HiFyre Data
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230821929092/en/
For Investor Relations enquiries: Max Schwartz
Director of Investor Relations investors@organigram.ca
Organigram
For Media enquiries: Megan McCrae Senior Vice
President – Marketing and Communications megan.mccrae@organigram.ca
Organigram
Organigram (NASDAQ:OGI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Organigram (NASDAQ:OGI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024